The year 2005 will portend a significant decrease in income for nearly every American urologist. Most will be impacted by Medicare's slashing the reimbursement for LHRH agonists and certain other drugs administered in the office. Solo practitioners can anticipate annual losses of income in the thousands of dollars, and larger group practices can expect over a $1 million shortfall this year.
Medicare’s G2211 and thoughts on how to best use it in urology
May 1st 2024"We felt that it was important to again address this topic because we have received numerous questions regarding the correct use of this code and we have had some experience using the code now that it is active and been able to observe some of the initial payment processing by the payer," write Jonathan Rubenstein, MD, and Mark Painter.
Experts develop guide on online tools to reduce costs of urologic drugs
April 22nd 2024"At a time when patients are increasingly concerned about prescription drugs, this information will provide a useful starting point for making essential medications as affordable as possible," says Ruchika Talwar, MD.